The results of the review were as follows:
The sensitivity and specificity of the screening test was 0.98.
Efficacy of mupirocin calcium was 0.91.
The risk of S aureus nasal carriage was 0.5.
The risk of S aureus infection in those with nasal carriage was 0.5.
The risk of S aureus infection attributable to nasal carriage was 0.75.
The probability of hospitalisation after site or systemic infection was 0.5.
The probability of shunt loss was 0.5.
The risk of shunt loss due to bacteremia after access site infection was 0.55.